These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 25434008)
1. Organ-specific protective role of NKT cells in virus-induced inflammatory demyelination and myocarditis depends on mouse strain. Kawai E; Sato F; Omura S; Martinez NE; Reddy PC; Taniguchi M; Tsunoda I J Neuroimmunol; 2015 Jan; 278():174-84. PubMed ID: 25434008 [TBL] [Abstract][Full Text] [Related]
2. Theiler's Virus-Mediated Immunopathology in the CNS and Heart: Roles of Organ-Specific Cytokine and Lymphatic Responses. Omura S; Kawai E; Sato F; Martinez NE; Minagar A; Al-Kofahi M; Yun JW; Cvek U; Trutschl M; Alexander JS; Tsunoda I Front Immunol; 2018; 9():2870. PubMed ID: 30619258 [TBL] [Abstract][Full Text] [Related]
3. Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1. Christophi GP; Massa PT Viral Immunol; 2009 Dec; 22(6):371-87. PubMed ID: 19951174 [TBL] [Abstract][Full Text] [Related]
4. CCR2 regulates development of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Bennett JL; Elhofy A; Charo I; Miller SD; Dal Canto MC; Karpus WJ Viral Immunol; 2007; 20(1):19-33. PubMed ID: 17425418 [TBL] [Abstract][Full Text] [Related]
5. Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS. Richards MH; Getts MT; Podojil JR; Jin YH; Kim BS; Miller SD J Autoimmun; 2011 Mar; 36(2):142-54. PubMed ID: 21273044 [TBL] [Abstract][Full Text] [Related]
6. Regulatory role of CD1d in neurotropic virus infection. Tsunoda I; Tanaka T; Fujinami RS J Virol; 2008 Oct; 82(20):10279-89. PubMed ID: 18684818 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of TGF-beta, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice. Chang JR; Zaczynska E; Katsetos CD; Platsoucas CD; Oleszak EL Virology; 2000 Dec; 278(2):346-60. PubMed ID: 11118358 [TBL] [Abstract][Full Text] [Related]
8. The level of viral infection of antigen-presenting cells correlates with the level of development of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Jin YH; Kang HS; Hou W; Meng L; Kim BS J Virol; 2015 Feb; 89(3):1867-78. PubMed ID: 25428872 [TBL] [Abstract][Full Text] [Related]
9. The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response. Gilli F; Li L; Pachner AR J Neurovirol; 2016 Feb; 22(1):66-79. PubMed ID: 26260496 [TBL] [Abstract][Full Text] [Related]
10. Facets of Theiler's Murine Encephalomyelitis Virus-Induced Diseases: An Update. Gerhauser I; Hansmann F; Ciurkiewicz M; Löscher W; Beineke A Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669615 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction. Karpus WJ; Pope JG; Peterson JD; Dal Canto MC; Miller SD J Immunol; 1995 Jul; 155(2):947-57. PubMed ID: 7608570 [TBL] [Abstract][Full Text] [Related]
12. Anticapsid immunity level, not viral persistence level, correlates with the progression of Theiler's virus-induced demyelinating disease in viral P1-transgenic mice. Myoung J; Bahk YY; Kang HS; Dal Canto MC; Kim BS J Virol; 2008 Jun; 82(11):5606-17. PubMed ID: 18353953 [TBL] [Abstract][Full Text] [Related]
13. The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations. Rodriguez M; Roos RP; McGavern D; Zoecklein L; Pavelko K; Sang H; Lin X Virology; 2000 Sep; 275(1):9-19. PubMed ID: 11017783 [TBL] [Abstract][Full Text] [Related]
14. Central nervous system Toll-like receptor expression in response to Theiler's murine encephalomyelitis virus-induced demyelination disease in resistant and susceptible mouse strains. Turrin NP Virol J; 2008 Dec; 5():154. PubMed ID: 19094215 [TBL] [Abstract][Full Text] [Related]
15. Membrane lymphotoxin is required for resistance to Theiler's virus infection. Lin X; Ma X; Rodriguez M; Feng X; Zoecklein L; Fu YX; Roos RP Int Immunol; 2003 Aug; 15(8):955-62. PubMed ID: 12882833 [TBL] [Abstract][Full Text] [Related]
16. Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease. Pullen LC; Park SH; Miller SD; Dal Canto MC; Kim BS J Immunol; 1995 Nov; 155(9):4497-503. PubMed ID: 7594613 [TBL] [Abstract][Full Text] [Related]
17. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. Katz-Levy Y; Neville KL; Girvin AM; Vanderlugt CL; Pope JG; Tan LJ; Miller SD J Clin Invest; 1999 Sep; 104(5):599-610. PubMed ID: 10487774 [TBL] [Abstract][Full Text] [Related]
18. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope. Gerety SJ; Rundell MK; Dal Canto MC; Miller SD J Immunol; 1994 Jan; 152(2):919-29. PubMed ID: 7506740 [TBL] [Abstract][Full Text] [Related]